Clinical trials recruiting in Pozzilli, Italy

Phase breakdown

Conditions recruiting in Pozzilli, Italy

Recruiting trials in Pozzilli, Italy

• A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
  NCT07067463 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female)
• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
  NCT07299019 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
  NCT07225504 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
  NCT05066217 · Phase: Phase 3 · Ages: 2 Years to 55 Years · Sex: All (male and female)
• Biomarkers of Synaptic Damage in Multiple Sclerosis
  NCT03217396 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
  NCT05811013 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Functional Study of Inhibitory Neurotransmission in the Human Epileptic Brain.
  NCT05459090 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.
  NCT07467460 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease
  NCT06965374 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)
  NCT06698159 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Pozzilli, Italy?

11 recruiting trials have at least one study site in Pozzilli, Italy.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.